Inve US ▾
AMAME

AMETEK (AME) Q1 FY26 earnings call: guidance and Q&A

Earnings call· Mar 2026 (Q1 FY26)· Industrials· Apr 30, 2026

Source: earnings call transcript

Executive summary

AMETEK Q1 FY26 — Record orders inflection lifts EPS guide amid conservative macro stance

AMETEK opened FY26 with a broad-based orders inflection — EIG's process and power businesses finally following EMG's earlier upturn — converting a long-signaled pipeline into record bookings while core margins expanded on greater-than-50% incremental flow-through. Management nudged up full-year EPS guidance but framed it as deliberately conservative against Middle East and tariff-driven macro uncertainty, keeping M&A the top capital-deployment priority alongside the First Aviation defense-MRO tuck-in.

Highlights

5
  • Record orders of $2.2B, up 23% (organic +22%) — a broad-based inflection with EIG organic orders +25% and EMG +16% — lifting backlog to a record $3.87B

  • Core operating margins expanded 160 bps to 27.9% (EMG core margins up a sharp 410 bps), with core incremental margins exceeding 50%

  • Adjusted diluted EPS of $1.97, up 13% and above the $1.85–$1.90 guide; record EBITDA of $620M at a 32.1% margin

  • Sales of $1.93B, up 11% (organic +5%, acquisitions +5 pts), with 107% free-cash-flow-to-net-income conversion

  • Signed First Aviation Services (~$80M annual sales) to broaden defense aftermarket; balance-sheet capacity to deploy well over $5B on M&A while staying investment-grade

Concerns

4
  • ~$15M of discrete Middle East orders (region ~2% of sales) did not ship in Q1 due to safety issues and disruptions

  • Commercial third-party aftermarket (<2% of sales) at risk from aviation-fuel shortages/costs, with weakness likely to appear in Asia first, then Europe

  • Tougher comps ahead: Medical FY guide of mid-single digits vs Q1's low-double-digit growth, and EMG H2 exit-rate ~mid-single despite double-digit orders

  • Management flagged tariff/input-cost inflation and geopolitical uncertainty, keeping full-year guidance deliberately conservative

Guidance & targets

CategoryTargetConfidence
Full-year revenue
Overall sales up high single digits; organic sales up mid-single digits
high materiality
High
Full-year adjusted diluted EPS
$7.94 to $8.14, up 7% to 10% vs prior year
high materiality
High
Q2 revenue
Overall sales up high single digits
medium materiality
High
Q2 adjusted EPS
$1.96 to $2.00, up 10% to 12% vs prior year
medium materiality
High
Free cash flow conversion
Approximately 110% to 115% of net income
medium materiality
High
Corporate G&A expense
Approximately 1.5% of sales
low materiality
High
Effective tax rate
Between 18.5% and 19.5%
low materiality
High
Capital expenditures
Approximately $160 million or about 2% of sales
medium materiality
High
Depreciation & amortization
Approximately $430M, incl. after-tax acquisition-related intangible amortization of ~$210M or $0.91 per diluted share
low materiality
High
Full-year incremental margin
35% incrementals
medium materiality
Medium
Full-year core operating margin
Core margins up around 50 basis points
medium materiality
Medium
Growth investment
Incremental $100 million, majority into RD&E and sales & marketing
medium materiality
High
Aerospace & Defense revenue
Up approximately 10% for FY26
medium materiality
Medium
Process (EIG subsegment) organic revenue
Up low to mid-single digits (raised from low)
medium materiality
Medium
Power (EIG subsegment) organic revenue
Up mid-single digits for FY26
medium materiality
Medium
Automation & Engineered Solutions organic revenue
Up mid-single digits for FY26
medium materiality
Medium
Medical end market revenue
Up mid-single digits for FY26
medium materiality
Medium

Segment performance

SegmentRevenueYoYQoQMargin
Electronic Instruments Group (EIG)
Double-digit sales growth with a meaningful inflection in orders; organic orders +25% broad-based across all EIG divisions and end markets, with notable growth in defense, power and semiconductor. Balance of sales growth from foreign currency.
Organic sales growth: +2%Acquisition contribution: +7 pointsOrganic orders growth: +25%Core operating margin: 31.4% (+40 bps YoY)Operating income: $376M (+6% YoY)
$1.26B+11%—Core operating margin 31.4% (+40 bps YoY); operating income $376M (+6% YoY)
Electromechanical Group (EMG)
Record segment sales; organic sales up double digits at 11% with strength broad-based across Automation & Engineered Solutions and Aerospace & Defense. Sizable core margin expansion from productivity plus volume leverage. EIG ($1.26B) + EMG ($664M) reconcile to the $1.93B company total.
Organic sales growth: +11%FX contribution: +2 pointsOrganic orders growth: +16%Core operating margin: 26% (+410 bps YoY)Operating income: $171M (+33% YoY)
$664M (record)+13%—Core operating margin 26% (+410 bps YoY); operating income $171M (+33% YoY)
Process (EIG subsegment)
Solid pipeline highlighted last quarter translated into broad-based order growth; metrology and materials-analysis businesses cited as strong order contributors. FY organic guide raised to low-to-mid single digits.
Organic sales growth: low single digitsOrders: broad-based growth on a growing pipeline
—+mid-teens (acquisitions + low-single-digit organic)——
Power (EIG subsegment)
Strong demand across power generation, backup power, data-center microgrids and power simulation systems; RTDS data-center-module product drove two new data-center testing orders. FY organic guide mid-single digits.
Orders: record level
—low single digits——
Automation & Engineered Solutions (EMG subsegment)
Excellent quarter across both the automation/engineered-solutions and EMIP businesses; demand across niche markets remains solid. FY organic guide mid-single digits.
Organic sales growth: high single digits
—high single-digit organic——
Aerospace & Defense (end market)
Broad-based strength with notable defense demand (missile defense, UAVs, naval/submarine, nuclear). Defense 'knocking it out of the park'; commercial OE and business-jet strong; MRO servicing airlines had an excellent orders quarter. FY outlook raised from high single digits to approximately 10%.
Company exposure: ~18% of salesDefense mix: ~60%Commercial mix: ~40%
—high single digits——
Medical (end market)
Great quarter led by Paragon (Record business also strong). Tougher comps in the balance of the year; FY expected mid-single digits.
Company exposure: a little over 20%
—low double digits——
United States (geography)
Very strong growth in Aerospace & Defense and Materials Analysis businesses.
—mid single digits——
Europe (geography)
Strength in power and automation, offset by modest Middle East headwinds; ~$15M of discrete orders did not ship in the quarter due to safety issues and disruptions.
—low single digits——
Asia (geography)
Strongest region; China up high teens driven by process and power markets.
China growth: high teens
—low double digits——

AME operating KPIs by quarter

AME operating KPIs stated on its earnings calls, by fiscal quarter
KPI Dec 2024 Q4 FY24 Mar 2025 Q1 FY25 Sep 2025 Q3 FY25 Dec 2025 Q4 FY25This call Mar 2026 Q1 FY26 Jun 2026 Q2 FY26Change vs prior quarter
Backlog
$3.4B with positive organic growth across both our EIG and EMG segments, and we ended the quarter with a strong backlog of $3.4 billion. Source: earnings call transcript
$3.47B Book-to-bill in the quarter was 1.04, and we ended the first quarter with a backlog of $3.47 billion near record levels. Source: earnings call transcript
$3.54B Orders were also very strong in the quarter with overall orders up 13% to a record $1.97 billion and organic orders up 7%, leading to a record backlog of $3.54 billion. Source: earnings call transcript
$3.58B Orders were very strong in the quarter with overall orders up 18% to a record $2 billion and organic orders up 7% versus the prior year, leading to a record backlog of $3.58 billion. Source: earnings call transcript
$3.87B Overall, orders were a record $2.2 billion, up 23% versus the prior year organic orders were up 22%, leading to a record backlog of $3.87 billion. Source: earnings call transcript
—+8.1%
Book-to-bill ratio —
1.04 ratio Book-to-bill in the quarter was 1.04, and we ended the first quarter with a backlog of $3.47 billion near record levels. Source: earnings call transcript
—
1.02 ratio So it was broad-based, and there was a similar pattern from Q3 and the book-to-bill of AMETEK was 1.02, and it was pretty broad-based. Source: earnings call transcript
—
1.12 ratio Our backlog was now $4.11 billion, up about 21% from the end of the year, and we had a positive book-to-bill of 1.12 in the quarter, both groups positive -- and we also are executing very well. Source: earnings call transcript
—
Vitality Index —
26% Our vitality index, which measures the sales of new products introduced in the past 3 years was a strong 26% in the first quarter. Source: earnings call transcript
26% The tangible results of this focus are clear with our third quarter Vitality Index, a strong 26%. Source: earnings call transcript
30% In the fourth quarter, our Vitality Index, which measures sales of new products introduced over the last 3 years was an outstanding 30%. Source: earnings call transcript
25% In the first quarter, our vitality index which measures sales of new products introduced over the last 3 years was an outstanding 25%. Source: earnings call transcript
25% In the second quarter, our new product vitality was a strong 25%. Source: earnings call transcript
0 pt
Orders ——
$1.97B Orders were also very strong in the quarter with overall orders up 13% to a record $1.97 billion and organic orders up 7%, leading to a record backlog of $3.54 billion. Source: earnings call transcript
$2B Orders were very strong in the quarter with overall orders up 18% to a record $2 billion and organic orders up 7% versus the prior year, leading to a record backlog of $3.58 billion. Source: earnings call transcript
$2.2B Overall, orders were a record $2.2 billion, up 23% versus the prior year organic orders were up 22%, leading to a record backlog of $3.87 billion. Source: earnings call transcript
$2.3B Overall orders were a record $2.3 billion, up 28% versus the prior year, with organic orders up sharply at 25%, being to a record backlog of $4.1 billion. Source: earnings call transcript
+4.5%

Operating figures the company stated on at least two of the calls shown, checked against each call's transcript. Click a figure to read the sentence. A dash means it was not stated that quarter.

Orderbook & backlog

Total backlog $3.87B 2026-03-31

Record level (driven by record orders of $2.2B, +23%)

Several large Q1 orders (defense, space, power, semiconductor) are for shipments across the balance of FY26, helping fill in the full-year sales outlook; not broken out by segment.

Product announcements

ProductTypeDetails
RTDS Technologies real-time simulator platform — data center moduleupdate

Deals & partnerships

First Aviation Services acquisition Price not disclosed; target has ~$80M in annual sales

Privately held provider of defense and aviation MRO services plus proprietary part design/manufacturing, with six U.S.-based centers of excellence. Primarily defense (some business-jet/commercial) across rotorcraft and fixed-wing platforms — propeller blades, rotor assemblies, landing gear, advanced electronics. Adds defense scale to AMETEK's largely commercial MRO business.

Risks & headwinds

Middle East conflict disrupting shipments / energy-market exposure Ongoing / near-term

~2% of sales exposed to the region (mostly EIG process/energy); ~$15M of discrete orders did not ship in Q1 due to safety issues and disruptions

Mitigation:Small direct exposure; no order cancellations, and seeing quotations to rebuild energy infrastructure; monitoring energy-market and spillover effects

Aviation-fuel availability/cost pressuring commercial third-party aftermarket Watching quarter-to-date; could change quickly

Third-party commercial aftermarket is <2% of sales

Mitigation:Strong backlog and execution; U.S. most insulated, any weakness expected first in Asia then Europe; downside seen as extremely modest

Tariff / input-cost inflation FY26

Not quantified in dollars

Mitigation:Expect to fully offset inflationary costs, including tariffs, with pricing; laser-focused on material input costs

Broader macro / geopolitical uncertainty FY26

Not quantified

Mitigation:Prudent, conservative guidance; distributed structure with business leaders close to customers monitoring for change

Tougher year-over-year comps in Medical and EMG Balance of FY26 (H2 weighted)

Medical FY guide mid-single digits vs Q1 low-double-digit growth; EMG H2 exit rate ~mid-single-digit despite double-digit organic orders

Mitigation:Order momentum and backlog support; comps normalize into the framing

Q&A highlights

Beyond the small Middle East exposure, are you seeing any buying hesitancy or macro pressure across regions?

Balanced growth: U.S. and international both up mid-single digits, Asia strongest (China up high teens on process/power), Europe up low single digits with modest Middle East headwinds (~$15M of orders unshipped on safety/disruptions). No cancellations or delays; in fact seeing quotations to rebuild energy infrastructure. March was an all-time record orders month.

“In fact, March was an all-time record of any quarter for orders at AMETEK.”

asked by Deane Dray · answered by David Zapico

3 min read 6 chapters

Detailed narrative

Record orders and the EIG inflection

Orders were a record $2.2 billion, up 23% (organic +22%), lifting backlog to a record $3.87 billion. Management framed the quarter as the long-signaled inflection where EIG follows EMG by roughly 6–9 months: EIG organic orders jumped 25% with notable strength in defense, power and semiconductor, while EMG organic orders rose 16%.

Every subsegment posted double-digit organic orders growth and every division was up at least 5%, so management stressed the strength was broad-based rather than lumpiness in a few areas. March was an all-time record month for orders, and April was tracking on target for another good month.

Large orders across defense, space, power and semiconductor

Several large orders aligned to attractive segments helped fill in the full-year sales outlook. In defense, AMETEK saw broad-based strength across missile defense, UAVs and naval applications, was selected on three UAV programs (one U.S., two with NATO allies), and booked strong EMIP fluid-transfer orders including for nuclear submarines.

Its Kern (Current Micro Technique) business won a sizable ultraprecision-machining order for RF components on low-earth-orbit satellites, and Abaco secured an agreement to supply advanced computing to a semiconductor-tool maker facing AI-driven demand. Commercial nuclear demand was also strong across fluid transfer, radiation detection and uninterruptible power solutions.

Margins and cash generation

Core operating margins expanded 160 bps to 27.9% (reported operating margins 26.8%, up 50 bps), with EMG core margins up a considerable 410 bps on productivity plus volume leverage and EIG up 40 bps on productivity. Core incremental margins exceeded 50% for the company and both groups.

Record EBITDA of $620M carried a 32.1% margin. Operating working capital improved 60 bps to 17.5% of sales, and free cash flow of $426M (up 8%) converted at 107% of net income. The company newly disclosed adjusted gross margin of 51% and will report it quarterly going forward.

Capital deployment and the First Aviation acquisition

With gross debt-to-EBITDA of 0.9x and net of 0.7x, AMETEK cited capacity to deploy well over $5 billion while retaining an investment-grade rating, with M&A the top priority. It signed a definitive agreement to acquire First Aviation Services, a privately held defense/aviation MRO and proprietary-parts provider with six U.S. centers of excellence and ~$80M in annual sales — roughly two-thirds MRO services and one-third proprietary (PMA/DER) parts across rotorcraft and fixed-wing platforms.

Management declined to disclose the price or comment on media speculation about a larger potential deal, reiterating a preference for 'bite-sized' deals that are a small percentage of market cap. It also raised the dividend 10% to $0.34/share, a seventh straight year of 10%+ increases.

Geographic performance and macro watch items

Growth was balanced: U.S. and international both up mid-single digits, with Asia strongest (up low double digits, China up high teens on process and power). The U.S. was led by A&D and Materials Analysis; Europe was up low single digits on power and automation but carried modest Middle East headwinds — about $15M of discrete orders did not ship due to safety issues and disruptions.

Middle East exposure is only ~2% of sales, mostly EIG process/energy, and management sees no cancellations, instead noting quotations to rebuild energy infrastructure. The company is watching aviation-fuel availability/costs for the small (<2%) third-party commercial aftermarket, expecting any softness to show first in Asia, then Europe, with the U.S. most insulated.

New product: RTDS data-center simulation

RTDS Technologies, a leader in real-time digital simulation of power systems, updated its simulator platform with a new data-center module and an updated workflow that more accurately represents third-party power solutions, helping data-center operators model UPS systems and variable-frequency drives used in power and cooling.

The innovation generated two notable Q1 orders for data-center testing from large power-equipment providers. Management also highlighted its ARTEMIS 2 support, where the Sensors and Fluid Management Systems business supplied thin-film pressure transducers for life-support infrastructure on the Orion crew vehicle, alongside four other AMETEK businesses (FMH, UEI, NSI, and Zygo Pixellink).

Summary of the company's earnings call; see how call summaries are prepared. Not investment advice.